NONINVASIVE PRENATAL DIAGNOSTIC METHODS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170321270A1
SERIAL NO

15587811

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Prenatal genetic testing allows early detection of genetic disease in a fetus. Described herein are methods of detecting the presence or absence of a genetic variant in a region of interest in the genome of a fetus in a pregnant woman. The methods are noninvasive, and can use cell-free DNA (cfDNA) present in the plasma of the pregnant woman. A DNA library is constructed from the cfDNA, and DNA molecules comprising the region of interest or portions thereof are enriched and analyzed, for example by sequencing. The methods described herein can also rely on constructing a maternal haplotype to provide even higher resolution fetal genetic variant determination.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYRIAD WOMEN'S HEALTH INC180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHU, Clement South San Francisco, US 18 385
EVANS, Eric Andrew Brisbane, US 20 199
HAQUE, Imran Saeedul San Francisco, US 26 208
MAGUIRE, Jared Robert Oakland, US 16 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation